CLINICAL IMMUNOLOGY
Interleukin-17 and interleukin-23 levels in gingival crevicular fluid of patients with chronic and aggressive periodontitis
 
More details
Hide details
 
Submission date: 2016-04-16
 
 
Final revision date: 2016-05-24
 
 
Acceptance date: 2016-06-21
 
 
Publication date: 2018-03-30
 
 
Cent Eur J Immunol 2018;43(1):76-80
 
KEYWORDS
ABSTRACT
Introduction:
Interleukin-17 is a pro-inflammatory cytokine with a wide range of protective and destructive effects in periodontitis. The role of IL-23 is stabilisation and expansion of Th-17. The aim of this study was to assess whether patients with aggressive and chronic periodontitis exhibit different gingival crevicular fluid (GCF) concentrations of IL-17 and IL-23 compared with clinically healthy subjects.

Material and methods:
GCF samples were obtained from 32 patients: 10 with chronic periodontitis (CP), 12 with aggressive periodontitis (AgP), and 10 healthy controls (HC). IL-23 and IL-17 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Comparison of study groups was performed with ANOVA and Tukey HSD tests. Spearman’s correlation coefficient was used to assess correlations between the variables.

Results:
IL-17 concentration was significantly higher in the healthy group compared to the AgP and CP groups (p < 0.001), but there were no significant differences between the CP and AgP groups. IL-23 levels in the healthy group were significantly higher than that in the AgP group (p < 0.001). Cytokine concentrations did not correlate significantly with probing depths and clinical attachment levels.

Conclusions:
Gingival crevicular fluid concentrations of IL-17 and IL-23 were significantly higher in the healthy group compared to periodontitis groups.
REFERENCES (35)
1.
Albandar JM (2014): Aggressive periodontitis: case definition and diagnostic criteria. Periodontology 65: 13-26.
 
2.
Johnson R, Wood N, Serio F (2004): Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 75: 37-43.
 
3.
Borch TS, Løbner M, Bendtzen K, et al. (2009): Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis. J Periodontol 80: 800-807.
 
4.
Salvi GE, Lang NP (2005): Host response modulation in the management of periodontal diseases. J Clin Periodontol 32: 108-129.
 
5.
Armitage GC (2010): Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontology 53: 70-88.
 
6.
Meng H, Xu L, Li Q, et al. (2007): Determinants of host susceptibility in aggressive periodontitis. Periodontology 43: 133-159.
 
7.
Ryder MI (2010): Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontology 53: 124-137.
 
8.
Duarte P, Bastos M, Fermiano D, et al. (2015): Do subjects with aggressive and chronic periodontitis exhibit a different cytokine/chemokine profile in the gingival crevicular fluid? A systematic review. J Periodont Res 50: 18-27.
 
9.
Shaker OG, Ghallab NA (2012): IL-17 and IL-11 GCF levels in aggressive and chronic periodontitis patients: relation to PCR bacterial detection. Mediators Inflamm. doi: http://dx.doi.org/10.1155/2012....
 
10.
Cifcibasi E, Koyuncuoglu C, Ciblak M, et al. (2015): Evaluation of local and systemic levels of interleukin-17, interleukin-23, and myeloperoxidase in response to periodontal therapy in patients with generalized aggressive periodontitis. Inflammation 38: 1959-1968.
 
11.
Gaffen S, Hajishengallis G (2008): A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87: 817-828.
 
12.
Gemmell E, Seymour GJ (1995):  T Lymphocytes in Human Periodontal Disease Tissue. J Periodontol 66: 780-785.
 
13.
Isaza-Guzmán D, Cardona-Vélez N, Gaviria-Correa D, et al. (2015): Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis. Arch Oral Biol 60: 91-99.
 
14.
Shaddox L, Wiedey J, Bimstein E, et al. (2010): Hyperresponsive phenotype in localized aggressive periodontitis. J Den Res 89: 143-148.
 
15.
Kulkarni C, Kinane DF (2014): Host response in aggressive periodontitis. Periodontology 65: 79-91.
 
16.
McKenzie BS, Kastelein RA, Cua DJ (2006): Understanding the IL-23–IL-17 immune pathway. Trends Immunol 27: 17-23.
 
17.
Zenobia C, Hajishengallis G (2015): Basic biology and role of interleukin-17 in immunity and inflammation. Periodontology 69: 142-159.
 
18.
Ohyama H, Kato-Kogoe N, Kuhara A, et al. (2009): The involvement of IL-23 and the Th17 pathway in periodontitis.
 
19.
J Dent Res 88: 633-638.
 
20.
Khader SA, Gaffen SL, Kolls JK (2009): Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2: 403-411.
 
21.
Hajishengallis G (2014): Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol 35: 3-11.
 
22.
Kotake S, Yago T, Kawamoto M, et al. (2012): Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial ‘human osteoclastology’. J Bone Miner Metab 30: 125-135.
 
23.
Vernal R, Dutzan N, Chaparro A, et al. (2005): Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Periodontol 32: 383-389.
 
24.
Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, et al. (2012): Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res 47: 525-531.
 
25.
Ay ZY, Yilmaz G, Özdem M, et al. (2012): The gingival crevicular fluid levels of interleukin-11 and interleukin-17 in patients with aggressive periodontitis. J Periodontol 83: 1425-1431.
 
26.
Cheng WC, Hughes FJ, Taams LS (2014): The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol 2014: 541-549.
 
27.
Duarte PM, da Rocha M, Sampaio E, et al. (2010): Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol 81: 1056-1063.
 
28.
Verreck FA, de Boer T, Langenberg DM, et al. (2004): Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria. Proc Nat Acad Sci USA 101: 4560-4565.
 
29.
Szkaradkiewicz A, Karpinski T, Zeidler A, et al. (2011): Protective effect of oral lactobacilli in pathogenesis of chronic periodontitis. Journal Physiol Pharmacol 62: 685-689.
 
30.
Lamster IB, Novak MJ (1992): Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 3: 31-60.
 
31.
Nędzi-Góra M, Kostrzewa-Janicka J, Gorska R (2013): Markers of inflammation in periodontal diseases. Cent Eur J Immunol 38: 363-366.
 
32.
Friedmann A, Ozmeric N, Bernimoulin J-P, et al. (2014): Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery. Cent Eur J Immunol 39: 508-517.
 
33.
Yetkin Ay Z, Sütçü R, Uskun E, et al. (2009): The impact of the IL-11: IL-17 ratio on the chronic periodontitis pathogenesis: a preliminary report. Oral Dis 15: 93-99.
 
34.
Lester SR, Bain JL, Johnson RB, et al. (2007): Gingival concentrations of interleukin-23 and-17 at healthy sites and at sites of clinical attachment loss. J Periodontol 78: 1545-1550.
 
35.
Azman R, Lappin DF, MacPherson A, et al. (2014): Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity. Inflamm Res 63: 1001-1012.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top